$CBUS
Cibus, Inc.

2019 Q2 Form 10-Q Financial Statement

#000119312519140080 Filed on May 08, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2019 Q1 2018 Q1
Revenue $408.0K $157.0K $11.00K
YoY Change 108.16% 1327.27% -80.0%
Cost Of Revenue $303.0K $34.00K $0.00
YoY Change
Gross Profit $105.0K $123.0K $11.00K
YoY Change -46.43% 1018.18% -80.0%
Gross Profit Margin 25.74% 78.34% 100.0%
Selling, General & Admin $6.408M $5.241M $2.676M
YoY Change 39.46% 95.85% 69.58%
% of Gross Profit 6102.86% 4260.98% 24327.27%
Research & Development $2.738M $2.219M $1.048M
YoY Change -11.48% 111.74% -17.22%
% of Gross Profit 2607.62% 1804.07% 9527.27%
Depreciation & Amortization $350.0K $342.0K $156.0K
YoY Change 62.79% 119.23% 17.29%
% of Gross Profit 333.33% 278.05% 1418.18%
Operating Expenses $9.597M $7.646M $4.307M
YoY Change 24.83% 77.52% 51.44%
Operating Profit -$9.492M -$7.523M -$4.296M
YoY Change 26.7% 75.12% 54.03%
Interest Expense $370.0K $370.0K $235.0K
YoY Change -613.89% 57.45% -1778.57%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$9.403M -$7.375M -$4.370M
YoY Change 24.12% 68.76% 54.31%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$9.403M -$7.375M -$4.370M
YoY Change 24.12% 68.76% 54.31%
Net Earnings / Revenue -2304.66% -4697.45% -39727.27%
Basic Earnings Per Share
Diluted Earnings Per Share -$287.2K -$225.8K -$156.9K
COMMON SHARES
Basic Shares Outstanding 32.70M shares 32.69M shares 28.06M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q2 2019 Q1 2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $76.40M $84.20M $50.70M
YoY Change -27.65% 66.07% 1590.0%
Cash & Equivalents $76.43M $84.23M $50.70M
Short-Term Investments
Other Short-Term Assets $1.900M $2.200M $2.100M
YoY Change 26.67% 4.76% 250.0%
Inventory $100.0K $379.0K
Prepaid Expenses
Receivables $800.0K $124.0K $0.00
Other Receivables $100.0K $200.0K $0.00
Total Short-Term Assets $79.30M $87.02M $52.83M
YoY Change -26.02% 64.72% 1327.84%
LONG-TERM ASSETS
Property, Plant & Equipment $22.50M $21.85M $18.77M
YoY Change 5.45% 16.45% 67.56%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.800M $674.0K $270.0K
YoY Change 486.32% 149.63% 35.0%
Total Long-Term Assets $24.30M $23.65M $19.04M
YoY Change 12.27% 24.22% 66.99%
TOTAL ASSETS
Total Short-Term Assets $79.30M $87.02M $52.83M
Total Long-Term Assets $24.30M $23.65M $19.04M
Total Assets $103.6M $110.7M $71.87M
YoY Change -19.59% 53.99% 375.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $400.0K $724.0K $441.0K
YoY Change -63.96% 64.17% -37.0%
Accrued Expenses $3.200M $1.610M $1.256M
YoY Change 63.35% 28.18% 25.6%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $300.0K $300.0K
YoY Change
Total Short-Term Liabilities $5.000M $4.650M $2.972M
YoY Change -0.83% 56.46% -25.7%
LONG-TERM LIABILITIES
Long-Term Debt $18.30M $18.20M $14.80M
YoY Change 5.17% 22.97%
Other Long-Term Liabilities $200.0K $156.0K $300.0K
YoY Change 100.0% -48.0% -50.0%
Total Long-Term Liabilities $18.50M $156.0K $15.10M
YoY Change 5.71% -98.97% 2416.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.000M $4.650M $2.972M
Total Long-Term Liabilities $18.50M $156.0K $15.10M
Total Liabilities $23.40M $22.97M $18.01M
YoY Change 3.53% 27.55% 283.13%
SHAREHOLDERS EQUITY
Retained Earnings -$89.82M -$58.92M
YoY Change 52.45%
Common Stock $177.8M $112.8M
YoY Change 57.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $80.19M $87.70M $53.86M
YoY Change
Total Liabilities & Shareholders Equity $103.6M $110.7M $71.87M
YoY Change -19.59% 53.99% 375.94%

Cashflow Statement

Concept 2019 Q2 2019 Q1 2018 Q1
OPERATING ACTIVITIES
Net Income -$9.403M -$7.375M -$4.370M
YoY Change 24.12% 68.76% 54.31%
Depreciation, Depletion And Amortization $350.0K $342.0K $156.0K
YoY Change 62.79% 119.23% 17.29%
Cash From Operating Activities -$6.590M -$9.276M -$6.565M
YoY Change 191.59% 41.29% 283.92%
INVESTING ACTIVITIES
Capital Expenditures -$970.0K $346.0K $41.00K
YoY Change 110.87% 743.9% -86.86%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$970.0K -$346.0K -$41.00K
YoY Change 110.87% 743.9% -86.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -230.0K 66.00K 645.0K
YoY Change -100.4% -89.77%
NET CHANGE
Cash From Operating Activities -6.590M -9.276M -6.565M
Cash From Investing Activities -970.0K -346.0K -41.00K
Cash From Financing Activities -230.0K 66.00K 645.0K
Net Change In Cash -7.790M -9.556M -5.961M
YoY Change -114.19% 60.31% 195.1%
FREE CASH FLOW
Cash From Operating Activities -$6.590M -$9.276M -$6.565M
Capital Expenditures -$970.0K $346.0K $41.00K
Free Cash Flow -$5.620M -$9.622M -$6.606M
YoY Change 212.22% 45.66% 226.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32702339 shares
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50703000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50703000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
53860000
CY2019Q1 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
130000
CY2019Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1610000
CY2019Q1 us-gaap Assets Current
AssetsCurrent
87023000
CY2019Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
887000
CY2019Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
124000
CY2019Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
177750000
CY2019Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
724000
CY2019Q1 us-gaap Assets
Assets
110671000
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
84231000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
85732000
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
275000000 shares
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32692189 shares
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32707725 shares
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
3000
CY2019Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
875000
CY2019Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
10200000
CY2019Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
264000
CY2019Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
18162000
CY2019Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
18400000
CY2019Q1 us-gaap Inventory Net
InventoryNet
379000
CY2019Q1 us-gaap Lessee Finance Lease Renewal Term1
LesseeFinanceLeaseRenewalTerm1
P5Y
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4650000
CY2019Q1 us-gaap Liabilities
Liabilities
22968000
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
110671000
CY2019Q1 us-gaap Lessee Finance Lease Term Of Contract1
LesseeFinanceLeaseTermOfContract1
P20Y
CY2019Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
674000
CY2019Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
290000
CY2019Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
156000
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21854000
CY2019Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1778000
CY2019Q1 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
1120000
CY2019Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
381000
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-89820000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
896478 shares
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1340631 shares
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.59
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3345280 shares
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.87
CY2019Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
230000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
87703000
CY2019Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
15536 shares
CY2019Q1 clxt Number Of Lease Extension Options
NumberOfLeaseExtensionOptions
4 Options
CY2019Q1 clxt Capital Lease Obligations Fair Value Disclosure
CapitalLeaseObligationsFairValueDisclosure
15600000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
56664000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
57476000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2007000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
95522000
CY2018Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
1305000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
176069000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
818000
CY2018Q4 us-gaap Assets
Assets
118791000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
93794000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
95288000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
275000000 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32648893 shares
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32664429 shares
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
3000
CY2018Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1905000
CY2018Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
46000
CY2018Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
258000
CY2018Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
18227000
CY2018Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
18500000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7004000
CY2018Q4 us-gaap Liabilities
Liabilities
25394000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
118791000
CY2018Q4 us-gaap Other Liabilities Fair Value Disclosure
OtherLiabilitiesFairValueDisclosure
248000
CY2018Q4 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
1000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
306000
CY2018Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
711000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
163000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21850000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1301000
CY2018Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
1113000
CY2018Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
381000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-82445000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1278038 shares
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.45
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3201887 shares
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.67
CY2018Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
230000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
93397000
CY2018Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
15536 shares
CY2018Q4 clxt Capital Lease Obligations Fair Value Disclosure
CapitalLeaseObligationsFairValueDisclosure
15800000
CY2018Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-68000
CY2018Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4917164 shares
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
40000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5961000
CY2018Q1 us-gaap Costs And Expenses
CostsAndExpenses
4307000
CY2018Q1 us-gaap Depreciation
Depreciation
156000
CY2018Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
49000
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2018Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-8000
CY2018Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-6000
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4370000
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2018Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-310000
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
880000
CY2018Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
182000
CY2018Q1 us-gaap Interest Expense
InterestExpense
235000
CY2018Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-456000
CY2018Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-68000
CY2018Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-439000
CY2018Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
167000
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-41000
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
645000
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6565000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-4370000
CY2018Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
4529000
CY2018Q1 us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
4946000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4296000
CY2018Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
81000
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
41000
CY2018Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
69000
CY2018Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
714000
CY2018Q1 us-gaap Profit Loss
ProfitLoss
-4370000
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1048000
CY2018Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11000
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
40000
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.537 pure
CY2018Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0
CY2018Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
714000
CY2018Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2676000
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.409 pure
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.025 pure
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.027 pure
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3260000
CY2018Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0 shares
CY2018Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2018Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
0
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
27851162 shares
CY2018Q1 clxt Increase Decrease In Due To From Related Parties Current
IncreaseDecreaseInDueToFromRelatedPartiesCurrent
-496000
CY2018Q1 clxt Share Based Compensation Arrangement By Share Based Payment Award Estimated Fair Value Of Stock Options Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardEstimatedFairValueOfStockOptionsGranted
10390
CY2018Q1 clxt Management Fees And Royalties
ManagementFeesAndRoyalties
583000
CY2018Q1 clxt Noncash Or Part Noncash Acquisition Deferred Costs In Accounts Payable And Accrued Liabilities
NoncashOrPartNoncashAcquisitionDeferredCostsInAccountsPayableAndAccruedLiabilities
417000
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1556000
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4385595 shares
CY2019Q1 dei Amendment Flag
AmendmentFlag
false
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1556000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9556000
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
34000
CY2019Q1 us-gaap Costs And Expenses
CostsAndExpenses
7680000
CY2019Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019Q1 us-gaap Depreciation
Depreciation
342000
CY2019Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2019Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019Q1 dei Document Type
DocumentType
10-Q
CY2019Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
56000
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
CY2019Q1 us-gaap Description Of Defined Contribution Pension And Other Postretirement Plans
DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans
We provide a 401(k) defined contribution plan for all regular full-time employees who have completed three months of service.
CY2019Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001705843
CY2019Q1 dei Entity Registrant Name
EntityRegistrantName
CALYXT, INC.
CY2019Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2019Q1 dei Document Period End Date
DocumentPeriodEndDate
2019-03-31
CY2019Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2019Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2019Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2019Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-24000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7375000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-94000
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
624000
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
124000
CY2019Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-397000
CY2019Q1 us-gaap Interest Expense
InterestExpense
370000
CY2019Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-418000
CY2019Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
172000
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
379000
CY2019Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-708000
CY2019Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
542000
CY2019Q1 us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
19700000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-346000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
125000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9335000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-7375000
CY2019Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 Segment
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7523000
CY2019Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
49000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
346000
CY2019Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
125000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-7375000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2044000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
157000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1556000
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y10M24D
CY2019Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.63
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
125000
CY2019Q1 dei Trading Symbol
TradingSymbol
CLXT
CY2019Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
13.29
CY2019Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
13.01
CY2019Q1 clxt Increase Decrease In Due To From Related Parties Current
IncreaseDecreaseInDueToFromRelatedPartiesCurrent
-1114000
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5241000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.789 pure
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.025 pure
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
2205 shares
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
353000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
180000 shares
CY2019Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0 shares
CY2019Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
34402 shares
CY2019Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2019Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
0
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
32677944 shares
CY2019Q1 clxt Share Based Compensation Arrangement By Share Based Payment Award Estimated Fair Value Of Stock Options Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardEstimatedFairValueOfStockOptionsGranted
9450
CY2019Q1 clxt Management Fees And Royalties
ManagementFeesAndRoyalties
361000

Files In Submission

Name View Source Status
0001193125-19-140080-index-headers.html Edgar Link pending
0001193125-19-140080-index.html Edgar Link pending
0001193125-19-140080.txt Edgar Link pending
0001193125-19-140080-xbrl.zip Edgar Link pending
clxt-20190331.xml Edgar Link completed
clxt-20190331.xsd Edgar Link pending
clxt-20190331_cal.xml Edgar Link unprocessable
clxt-20190331_def.xml Edgar Link unprocessable
clxt-20190331_lab.xml Edgar Link unprocessable
clxt-20190331_pre.xml Edgar Link unprocessable
d692228d10q.htm Edgar Link pending
d692228dex311.htm Edgar Link pending
d692228dex312.htm Edgar Link pending
d692228dex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g692228page4.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending